Key Details
Price
$1.27Annual ROE
383.46%Beta
2.28Events Calendar
Next earnings date:
Dec 13, 2024Recent quarterly earnings:
Sept 11, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
July 16, 2024Analyst ratings
Recent major analysts updates
11 Nov '24 Ascendiant Capital
Buy12 Apr '23 Maxim Group
Buy01 Oct '21 Ascendiant Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Alzamend Neuro doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024
ALZN
InvestorPlace24 May 2023
Developing groundbreaking drugs and devices entails high costs, uncertain regulatory approval, and lucrative revenues. Those factors and more culminate to create a sector filled with dozens of biotech stocks that have 10X potential, or better.
3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year
ALZN
InvestorPlace11 May 2023
Turning $1,000 into $10,000 in a year in the stock market is undoubtedly a lofty goal. Make no bones about it, it's not particularly likely to happen.
FAQ
- What is the primary business of Alzamend Neuro?
- What is the ticker symbol for Alzamend Neuro?
- Does Alzamend Neuro pay dividends?
- What sector is Alzamend Neuro in?
- What industry is Alzamend Neuro in?
- What country is Alzamend Neuro based in?
- When did Alzamend Neuro go public?
- Is Alzamend Neuro in the S&P 500?
- Is Alzamend Neuro in the NASDAQ 100?
- Is Alzamend Neuro in the Dow Jones?
- When was Alzamend Neuro's last earnings report?
- When does Alzamend Neuro report earnings?
- Should I buy Alzamend Neuro stock now?
What is the primary business of Alzamend Neuro?
Alzamend Neuro is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, such as Alzheimer's and Parkinson's. They aim to improve patients' quality of life through advanced therapies and research, working to bring new solutions to the market for these challenging conditions.
What is the ticker symbol for Alzamend Neuro?
The ticker symbol for Alzamend Neuro is NASDAQ:ALZN
Does Alzamend Neuro pay dividends?
No, Alzamend Neuro does not pay dividends
What sector is Alzamend Neuro in?
Alzamend Neuro is in the Healthcare sector
What industry is Alzamend Neuro in?
Alzamend Neuro is in the Biotechnology industry
What country is Alzamend Neuro based in?
Alzamend Neuro is headquartered in United States
When did Alzamend Neuro go public?
Alzamend Neuro's initial public offering (IPO) was on 15 June 2021
Is Alzamend Neuro in the S&P 500?
No, Alzamend Neuro is not included in the S&P 500 index
Is Alzamend Neuro in the NASDAQ 100?
No, Alzamend Neuro is not included in the NASDAQ 100 index
Is Alzamend Neuro in the Dow Jones?
No, Alzamend Neuro is not included in the Dow Jones index
When was Alzamend Neuro's last earnings report?
Alzamend Neuro's most recent earnings report was on 11 September 2024
When does Alzamend Neuro report earnings?
The next expected earnings date for Alzamend Neuro is 13 December 2024
Should I buy Alzamend Neuro stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions